Hemoglobin status in children in the age group 6 to 60 months

B L Bajracharya1, D S Manandhar, M R Baral

  • 1Kathmandu Medical College Teaching Hospital, Sinamangal, Kathmandu, Nepal. blbajracharya@mail.com.np

Insights

This study found a high prevalence of anemia in children aged 6-60 months in Kathmandu. Poverty, illiteracy, and poor nutrition awareness contribute to childhood anemia, necessitating iron supplementation.

Area of Science:

  • Pediatrics
  • Public Health
  • Nutritional Science

Background:

  • Childhood anemia is a significant global health concern.
  • Anemia affects cognitive development and overall child health.
  • Understanding prevalence and risk factors is crucial for intervention.

Purpose of the Study:

  • To determine the prevalence of anemia in children aged 6-60 months.
  • To identify associated factors contributing to anemia in the study population.
  • To inform targeted public health strategies for anemia prevention.

Main Methods:

  • A cross-sectional study was conducted at Kathmandu Medical College's pediatric outpatient department.
  • 100 children aged 6-60 months were randomly selected.
  • Hemoglobin levels, anthropometry (height, weight, BMI), and socioeconomic factors were assessed.

Main Results:

  • 46% of children exhibited hemoglobin levels below 11 gm/dl, indicating anemia.
  • A significant proportion of anemic children were malnourished.
  • Poverty, low parental education levels, and lack of nutritional awareness were strongly associated with anemia.

Conclusions:

  • High childhood anemia prevalence necessitates urgent public health interventions.
  • Targeted iron supplementation is recommended, especially for children aged 6 months to 3 years.
  • Addressing socioeconomic determinants and improving nutritional education are vital for long-term anemia control.

Related Concept Videos

Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Hemoglobin01:24

Hemoglobin

Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.